Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pituitary Neoplasms 2Leukemia 2Radiodermatitis 1Prostatic Neoplasms 1Pituitary Diseases 1Leukemia, Biphenotypic, Acute 1Breast Neoplasms 1Adrenal Insufficiency 1

Interventions

Standard of Care 5Low-Level Light Therapy 5Petrolatum 2triethanolamine 1eucerin 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1Zinc Oxide 1Thioctic Acid 1Sodium Chloride 1Silver Sulfadiazine 1Practice Guidelines as Topic 1Laser Therapy 1Hydrogel, Polyethylene Glycol Dimethacrylate 1Hydrocortisone 1Gels 1Centella asiatica extract 1Biafine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Radiodermatitis × Hydrocortisone × Clear all
NCT05073172 2024-05-06

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

OHSU Knight Cancer Institute

Phase NA Withdrawn
Breast

Breast Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡